| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 0 | 2 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | 941 | 5.405 | 13.663 | 116 | 0 | 0 |
| Gross Profit/Loss - EUR | - | - | - | - | -941 | -5.405 | -13.661 | -116 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | - | - | -941 | -5.405 | -13.661 | -116 | 0 | 0 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Afibiotech S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.531 | 21.887 | 21.402 | 21.468 | 21.403 | 21.284 |
| Current Assets | - | - | - | - | 141 | 94 | 3.601 | 3.505 | 3.495 | 3.475 |
| Inventories | - | - | - | - | 62 | 60 | 3.091 | 3.042 | 3.032 | 3.015 |
| Receivables | - | - | - | - | 0 | 0 | 457 | 464 | 462 | 460 |
| Cash | - | - | - | - | 80 | 33 | 52 | 0 | 0 | 0 |
| Shareholders Funds | - | - | - | - | -899 | -6.286 | -19.808 | -19.985 | -19.924 | -19.813 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 6.343 | 28.268 | 44.811 | 44.958 | 44.822 | 44.571 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Afibiotech S.r.l.